Larimar Therapeutics, Inc. (LRMR) › Shares OutstandingLarimar Therapeutics, Inc. (LRMR) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 729.4K2014: 22.88M2015: 27.24M2016: 27.33M2017: 27.49M2018: 37.29M2019: 6.09M2020: 15.37M2021: 17.71M2022: 43.27M2023: 43.91M2024: 63.82M2025: 83.09M83.09M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202583.09M+30.2%202463.82M+45.3%202343.91M+1.5%202243.27M+144.3%202117.71M+15.2%202015.37M+152.3%20196.09M-83.7%201837.29M+35.6%201727.49M+0.6%201627.33M+0.3%201527.24M+19.1%201422.88M+3036.7%2013729.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share